ArticleThe Journal of clinical endocrinology and metabolism2025

Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare Obesity Syndrome.

Moritz Ferch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.